FDA reports Tarceva deaths; CT doctors dissatisfied with state;

>  Two patients died following liver damage related to taking the cancer drug Tarceva, according to a letter the FDA has posted. FiercePharma

> Investments in technology are crucial for the survival and continued success for hospitals everywhere, but few hospitals seem to have a disciplined approach to truly evaluating the technology's value. Hospital Impact

> Bad news for Connecticut's healthcare industry: One-third of the state's doctors say they're thinking about changing jobs or leaving the state because they don't like the practice environment there. Article

> Particularly given the changes that could sweep through with the election of a new president and members of Congress, it's time to pay special attention to unionization at your facility, observers say. FierceHealthFinance

> Here's a nasty dilemma: A Massachusetts hospital is struggling to protect its balance sheet and credit rating after admissions collapsed in the wake of a new $57.5 million investment. FierceHealthFinance

And Finally... He may be (very, very) old, but he's still sharp. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.